Unresectable Urothelial Carcinoma

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer [Phase 3]

  This Phase 3 trial is evaluating pembrolizumab plus sacituzumab govitecan versus standard of care for locally advanced, unresectable, or met…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]

  This Phase 2 trial update tests atezolizumab with or without eribulin mesylate in patients with recurrent locally advanced or metastatic uro…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy [Phase 1]

  Phase 1 clinical trial evaluating pembrolizumab in combination with CA-4948 for progressive metastatic urothelial cancer, currently recruiti…

• CLINICAL_TRIALS research · 2026-02-19
  Clinical Trial Update: Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma [Phase 2]

  Phase 2 trial evaluating pembrolizumab maintenance after enfortumab vedotin/pembrolizumab induction as front-line treatment for metastatic u…

• CLINICAL_TRIALS trial_result · 2020-02-17
  Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer [Phase 3]

  Phase 3 trial evaluating gemcitabine hydrochloride and cisplatin with or without bevacizumab in advanced urothelial carcinoma/metastatic uro…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.